These data, coupled with functional data from fibroblasts (Fig 6), suggest that cancer cell motility is regulated by BNC2 via two independent but converging mechanisms; directly by altering the nature of the cancer cells themselves (for those in which BNC2 is naturally expressed), and indirectly through cancer-associated fibroblasts that produce and remodel the ECM. Here, BNC2 is linked to cancer.